Specialised - Recombinant Factor IX
key details
| Value | £42,700,000 |
|---|---|
| Status | planned |
| Category (CPV) | 33141530 |
| Contract start | 1 Sept 2017 |
| Contract end | 31 Aug 2018 |
| SME suitable | Yes |
| OCID | ocds-b5fd17-c5625502-e7c3-4ca2-856a-ea1ceb78311d |
description
Specialised - Recombinant Factor IX
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 10 Mar 2017 | Planning (planning) | · | f1c851cf-cd85-4e57-b8d5-af2fe5531e78-134709 |
| 18 Oct 2018 | Planning (planning) | · | aba390a8-8917-4d9d-82aa-9271523b8a09-247151 |
more from DEPARTMENT OF HEALTH
- DoH - Action 17 Mental Health Strategy Community and Voluntary Sector Review · £130,000 · 17 Dec 2024
- ID 4345494 - Mental Health Champion Advertising Campaign · £420,000 · 9 Dec 2022
- ID 4231904 DAC55/22 - Stenography Services for Urology Services Inquiry and Muckamore Abbey Hospital Inquiry · 6 May 2022
- ID 4019972 - DoH - Provision of Audio Visual/Web Streaming Services and the Electronic Presentation of Evidence to support the Muckamore Abbey Hospital Inquiry and Urology Services Inquiry · £700,000 · 25 Apr 2022
- Care Provider Delivery Partner · £50,000 · 22 Jun 2021
- Herpes zoster (shingles) vaccines purchased, held centrally and distributed by the Department of Health in support of the immunisation programme · 21 May 2020
- Strategic stockpile of medicines 2021 · 21 May 2020
- HPV Vaccine (04-2021) · 30 Jan 2020
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Purchase of Diathermy · Leeds Teaching Hospitals NHS Trust · £48,000
- NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B · NHS England · £192,000,000
- Provision of R-Phycoerythrin F(ab)2-specific IgG antibody · Public Health England · £44,601
- National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders · NHS England · £302,000,000
- HOME DELIVERY OF RECOMBINANT COAGULATION FACTORS FOR HAEMOPHILIA PATIENTS · University Hospitals of North Midlands NHS Trust
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.